Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN101792400A details a high-yield four-step route for Agomelatine, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113149937A details a novel one-pot two-step synthesis of bio-based diamines. Discover cost reduction in polymer additive manufacturing and high-purity production capabilities.
Patent CN116947830A reveals metal-free visible light synthesis for coumarin heterocycles, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel copper-catalyzed method offers high yield and safety for pharmaceutical intermediates manufacturing supply chain ensuring reliable global sourcing and substantial cost efficiency.
Patent CN108368050A details improved crotonyl aminopyridine synthesis yielding high purity intermediates. This process reduces purification steps and enhances supply chain reliability for global pharmaceutical manufacturers seeking cost effective solutions.
Patent CN1931857A reveals a scalable permanganate oxidation route for Losartan 5-carboxylate (EXP-3174), offering high purity and eliminating chromatography for cost-effective API manufacturing.
Patent CN104529935A enables high-purity synthesis with reduced steps. Delivers significant cost reduction and supply chain reliability for global buyers.
Patent CN103073492A details a green Ru-catalyzed transfer hydrogenation for Montelukast intermediates, offering significant cost reduction and supply chain reliability.
Advanced preparation of cyclohexene carboxylates for neuraminidase inhibitors. Optimized route offers cost reduction and scalable manufacturing for API intermediates.
Patent CN103360458B details a novel Abiraterone synthesis route avoiding palladium. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel one-step secnidazole preparation improves yield to 60% and reduces solvent use for cost effective pharmaceutical manufacturing supply chains.
Patent CN106749447A reveals a stable ketal protection route for epirubicin synthesis, offering high purity and cost reduction in API manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN106674264A reveals high-yield route for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN118955504B reveals visible light cobalt catalysis for hexahydro beta carboline indole compounds offering safer greener pharmaceutical intermediate manufacturing supply chain advantages.
Novel 3-step route for Rivaroxaban intermediate reduces waste and cost. High purity API intermediate manufacturing via efficient isonitrification.
Patent CN114591273A reveals a solid-state synthesis route for high-purity Alfuzosin intermediates, offering superior stability and cost reduction in pharmaceutical manufacturing.
Patent CN102675283A reveals a novel acid-catalyzed condensation route for Bepotastine intermediates, offering superior chiral purity and yield compared to traditional base-mediated methods.
Optimized Dasatinib synthesis patent CN103554099B ensures high purity and stability. Delivers significant cost reduction and supply chain reliability for API manufacturing.